|
|
| 5-Day | 2,998 |
| 10-Day | 2,280 |
| 30-Day | 873 |
| 5-Day | 2,998 |
| 10-Day | 2,280 |
| 30-Day | 873 |
Ishita Drugs is not listed on NSE
Only Sellers
Only Sellers in Ishita Drugs on BSE52 Week Low
Ishita Drugs has hit 52wk low of Rs 12.10 on BSE52 Week Low
Ishita Drugs has hit 52wk low of Rs 12.66 on BSE52 Week Low
Ishita Drugs has hit 52wk low of Rs 13.32 on BSE52 Week Low
Ishita Drugs has hit 52wk low of Rs 13.32 on BSE52 Week Low
Ishita Drugs has hit 52wk low of Rs 14.02 on BSEOnly Sellers
Only Sellers in Ishita Drugs on BSE52 Week Low
Ishita Drugs has hit 52wk low of Rs 15.00 on BSEOnly Sellers
Only Sellers in Ishita Drugs on BSEOnly Sellers
Only Sellers in Ishita Drugs on BSEOnly Sellers
Only Sellers in Ishita Drugs on BSEOnly Sellers
Only Sellers in Ishita Drugs on BSEOnly Sellers
Only Sellers in Ishita Drugs on BSEOnly Sellers
Only Sellers in Ishita Drugs on BSEOnly Sellers
Only Sellers in Ishita Drugs on BSE52 Week High
Ishita Drugs has hit a 52wk high of Rs 33.00 on BSE52 Week High
Ishita Drugs has hit a 52wk high of Rs 31.50 on BSEAnnouncements
Ishita Drugs & Industries: Outcome of AGMOnly Sellers
Only Sellers in Ishita Drugs on BSEAnnouncements
Ishita Drugs: Outcome of AGM
| Days | BSE | NSE |
| 30 | 18.31 | |
| 50 | 22.20 | |
| 150 | 0.00 | |
| 200 | 0.00 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Ishita Drugs
| Standalone | (Dec '13) | (Sep '13) |
| Net Sales | 1.44 | 2.12 |
| Other Income | 0.02 | 0.02 |
| PBDIT | 0.07 | 0.14 |
| Net Profit | 0.03 | 0.07 |
Annual Report
| Total Share Capital | 2.99 |
| Net Worth | 5.07 |
| Total Debt | 0.11 |
| Net Block | 1.17 |
| Investments | 1.21 |
| Net Current Assets | 2.75 |
| Total Assets | 5.16 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 626.10 | 1.09 | 653.10 | 481.50 | 129,675.57 |
| Lupin | 987.25 | 0.52 | 1012.00 | 693.70 | 44,265.90 |
| Dr Reddys Labs | 2565.45 | 0.50 | 2939.80 | 1999.40 | 43,640.58 |
| Cipla | 399.65 | 0.58 | 450.00 | 375.00 | 32,088.75 |
| GlaxoSmithKline | 2463.15 | -0.95 | 3054.40 | 2225.00 | 20,863.62 |
| More » | |||||
| Dec' 13 | Sep' 13 | Jun' 13 | Mar' 13 | |
| Promoter | 46.18 | 46.18 | 46.18 | 46.18 |
| FII | 0.00 | 0.00 | 0.00 | 0.00 |
| DII | 0.00 | 0.00 | 0.00 | 0.00 |
| Others | 53.82 | 53.82 | 53.82 | 53.82 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| No Mutual Funds Holding the share |
Ishita Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 4.48 crore.The company has reported a standalone sales of Rs 1.44 crore and a Net Profit of Rs 0.03 crore for the quarter ended Dec 2013.
The company management includes Jagdish Agrawal - Managing Director, Niranjan Agrawal - Director, P R Rastogi - Director, Govind Gupta - Director, S K Agrawal - Director, Abha Agrawal - Director.
It is listed on the BSE with a BSE Code of 524400.
Its Registered office is at Survey No.179/1, Vasana Iyava Village,,Sanand Taluk Ahmedabad,Gujarat - 382170.
SET SMS ALERT
